NCT05745363 2025-12-16
Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Completed
Clinical Trials
8 trialsNCT07115810 2025-08-11
No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort
King Faisal Specialist Hospital & Research Center
Completed
NCT01876784 2024-07-23
VERIFY
Sanofi
Phase 3 Completed
NCT04971473 2024-03-28
Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3 Completed
NCT04137185 2024-03-06
Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2 Completed
NCT03986437 2021-05-27
MEDIRAD
Institut Claudius Regaud
Completed
NCT02870569 2019-03-01
Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 2 Completed
NCT03191643 2017-06-19
PET-guided External Beam Radiotherapy in Differentiated Thyroid Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Completed